Saudi Arabia:
On 27 February 2020 a Saudi nationality person returning to Saudi Arabia via Bahrain from Iran without knowing that he has infected but on 2 March, Saudi Arabia reported that the man has infected with SARS-COVID 19.This made Saudi Arabia to announce a temporary lockdown the Great Mosque of Mecca and the Prophet’s Mosque in Madinah but later they decided to reopen the mosques only except for the Great Mosque of Mecca, with the very preventive health measure against the virus. To prevent further outbreaks of the infection Saudi Arabia Government announced a travel ban between Kingdom and China , and they decided to suspend the entrance of other cooperation council citizens into the country and vice versa. And later they counseled all internal flights, trains, buses, taxis for only 14 days like a big effort to obstacle the COVID19 spreading. Saudi Arabia’s health ministry has approved the use of the steroid dexamethasone as part of its treatment protocol for COVID-19 patients, Saudi Press Agency reported on Wednesday Dexamenthasone has been used to treat inflammation in diseases such as arthritis.(WHO) said on Wednesday it would be updating its clinical guidelines on COVID-19 treatment to include the results of the preliminary trial conducted by University of Oxford researchers
The Russian Direct Investment Fund (RDIF), the country’s sovereign wealth fund which has collaborated with the Kingdom on many investment projects, is set to unveil the new drug, Avifavir, at a virtual press conference in Moscow. RDIF said that the drug, which “has shown high efficacy in treating patients with coronavirus during clinical trials,” had received a registration certificate from the Russian health ministry.. Our partners expressed interest in starting a clinical trial of Avifavir in the Kingdom.” Avifavir, which disrupts the reproduction mechanisms of coronavirus, Favipiravir is a drug that has proven effective in the treatment of infected patients in China and in clinical trials in Russia.